News

The company proposed the injection for the treatment of symptomatic Vitreomacular Adhesion (VMA) including macular hole. ThromboGenics CEO Patrik De Haes said that the FDA has granted ocriplasmin

Mylan gained final FDA approval for its abbreviated new drug application for Desloratadine Tablets, 5mg, and is shipping the product immediately. According to IMS Health, Desloratadine Tablets, 5mg,

The particulate matter, which has been recognized as a potential health hazard, was identified as active drug substance and not foreign material or contamination. Vein irritation and phlebitis,

According to ThermoGenesis, the payment is due during the company’s first fiscal quarter of 2013. ThermoGenesis chief executive officer Matthew Plavan said the divestiture is an important milestone

The international, multicentre, randomised trial will evaluate the safety and efficacy of lucanthone administered in combination with temozolomide (TMZ) and radiation treatment. Spectrum Pharmaceuticals chairman, president and chief

With the additional funding, the total contract is now valued at CA$7.7m ($7.6m). In the next development phase, the company will enhance the capability of the original solution,

The Extedo solution will validate, import, and review electronic submission information sent by pharmaceutical companies on electronic media such as CDs or DVDs. Extedo CEO Tore Bergsteiner said

The assets under certain liabilities include Great Southern’s buildings and land located in Houston, Texas, US. The acquisition will enable Pernix to improve the company’s gross margins on

Norgestimate and Ethinyl Estradiol tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Lupin’s Norgestimate and